Crescenta Biosciences is a pioneering new small molecule drug discovery company focused on developing novel therapeutic approaches for the treatment of human disease. Our unique approach leverages the power of the very latest technologies in chemistry, biology, and physics with end-to-end engineering of our central drug discovery platform to facilitate and accelerate the drug discovery process.

Our proprietary platform consists of a novel chemical library pre-enabled for target discovery, an array of advanced biological assays in disease models, and next-generation mass spectrometry specifically designed to identify key pharmacophores on conventional and unconventional protein targets. Our platform has profound biomedical and commercial applications based on its capacity to develop drugs with novel mechanism of action and its ability to identify on-target and potential off-target interactions at a critical early stage in drug development. 

Learn More  →